Klaus Orlinger
Chief Tech/Sci/R&D Officer bij HOOKIPA PHARMA INC.
Vermogen: 7 408 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Klaus Orlinger
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 26 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Klaus Orlinger via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Public Communications Contact | |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Dunbar Capital Management LLC
Dunbar Capital Management LLC Investment ManagersFinance Part of Dunbar Capital Investors LLC, Dunbar Capital Management LLC is a private company based in Whippany, NJ. | Investment Managers | Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal | |
ILC Dover LP
ILC Dover LP Pharmaceuticals: MajorHealth Technology ILC Dover LP operates as an engineering development and manufacturing company, which specializes in the use of flexible materials, serving the aerospace, personal protection, and pharmaceutical industries. Its products include lighter-than-air structures, personal protection equipment, engineered inflatables, powder containment, industrial containment, space suites, space inflatables, and specialty materials. The company was founded in 1947 and is headquartered in Federica, DE. | Pharmaceuticals: Major | Director/Board Member | |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Masters Business Admin | |
Vassar College | College/University | Undergraduate Degree | |
University College Dublin | College/University | Masters Business Admin | |
Trinity College Dublin | College/University | Undergraduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
Universität Salzburg | College/University | Graduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
University of Basel | College/University | Corporate Officer/Principal | |
University of Geneva | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
The Sidney Kimmel Comprehensive Cancer Center
The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Advancion Corp.
Advancion Corp. Chemicals: SpecialtyProcess Industries Advancion develops and delivers distinct nitro alkane and derivatives. Its markets include paints and coatings, metalworking fluids, water treatment, personal care, life sciences, wood adhesives, leather tanning, synthesis, and synthetic rubber. The company was founded in 1936 and is headquartered in Buffalo Grove, IL. | Chemicals: Specialty | Director/Board Member | |
Institut Gustave Roussy EURL
Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Chamber of Commerce Ireland
American Chamber of Commerce Ireland Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce Ireland is a leading international business organization that supports the Transatlantic business relationship. The non-profit company is based in Dublin, Ireland. The Irish company provides networking opportunities, leadership development programs, and representation to government, media, and stakeholders. The company's highly sought-after programs operate virtually and in person, supporting individual growth within their member companies. The CEO of the company is Mark Redmond. | Miscellaneous Commercial Services | Director/Board Member | |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Biotechnology | Director/Board Member | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer Chairman Director/Board Member Director/Board Member Founder Director/Board Member | |
UNIQURE N.V. | Biotechnology | Chief Executive Officer Founder | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
NASDAQ
NASDAQ Investment Banks/BrokersFinance Part of Nasdaq, Inc., NASDAQ is a stock exchange. | Investment Banks/Brokers | Corporate Officer/Principal | |
Gilead Sciences Ireland UC | Chief Operating Officer | ||
GRITSTONE BIO, INC. | Biotechnology | Founder | |
RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
GeneSpire Srl
GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chairman Director/Board Member | |
Baltimore Bays Soccer Club | Corporate Officer/Principal | ||
Université Paris-Saclay | College/University | Corporate Officer/Principal | |
ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
IDRx, Inc.
IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistieken
Internationaal
Verenigde Staten | 27 |
Ierland | 8 |
Frankrijk | 6 |
Oostenrijk | 4 |
Duitsland | 3 |
Sectoraal
Health Technology | 23 |
Commercial Services | 10 |
Consumer Services | 10 |
Finance | 7 |
Health Services | 2 |
Operationeel
Director/Board Member | 92 |
Corporate Officer/Principal | 66 |
Independent Dir/Board Member | 25 |
Chief Tech/Sci/R&D Officer | 22 |
Director of Finance/CFO | 16 |
Sterkste connecties
Insiders | |
---|---|
Graziano Seghezzi | 26 |
Michael Kelly | 19 |
Sander J. van Deventer | 17 |
Christoph S. Lengauer | 16 |
Julie O'Neill | 16 |
Jan van de Winkel | 15 |
Jörn Aldag | 15 |
Mary Coelho | 12 |
Victor Paulus | 12 |
Malte Peters | 11 |
Reinhard Kandera | 10 |
David Kaufman | 10 |
Matthew Beck | 10 |
Jean-Charles Soria | 10 |
Roman Necina | 9 |
- Beurs
- Insiders
- Klaus Orlinger
- Bedrijfsconnecties